Interferon-β treatment of cervical keratinocytes naturally infected with human papillomavirus 16 episomes promotes rapid reduction in episome numbers and emergence of latent integrants

Carcinogenesis

Volumn 27, Issue 11, 2006, Pages 2341-2353

  Herdman, Trent M ^a   Pett, Mark R ^a   Roberts, Ian ^a   Alazawi, William O F ^a   Teschendorff, Andrew E ^b   Zhang, Xiao Yin ^a   Stanley, Margaret A ^b   Coleman, Nicholas ^a,b  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; PROTEIN E6; PROTEIN E7; RECOMBINANT BETA INTERFERON;

ARTICLE; BOVINE PAPILLOMAVIRUS; CELL DEATH; CELL KINETICS; CONTROLLED STUDY; EPISOME; GENE NUMBER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 6; IMMUNE RESPONSE; KERATINOCYTE; NONHUMAN; PAPILLOMA VIRUS; POPULATION; PRIORITY JOURNAL; RNA TRANSLATION; UTERINE CERVIX; VIRUS CARCINOGENESIS; VIRUS DNA CELL DNA INTERACTION; VIRUS INHIBITION; VIRUS MORPHOLOGY; VIRUS TRANSCRIPTION;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CERVIX UTERI; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; INTERFERON-BETA; KERATINOCYTES; MICE; PAPILLOMAVIRUS INFECTIONS; TIME FACTORS; TRANSFECTION;

EID: 33750440566     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl172     Document Type: Article

References (50)

1. Münger,K., Baldwin,A., Edwards,K.M., Hayakawa,H., Nguyen,C.L., Owens,M., Grace,M. and Huh,K. (2004) Mechanisms of human papillomavirus-induced oncogenesis. J. Virol., 78, 11451-11460.
2. Longworth,M.S. and Laimins,L.A. (2004) Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol. Mol. Biol. Rev., 68, 362-372.
3. Dürst,M., Kleinheinz,A., Hotz,M. and Gissman,L. (1985) The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J. Gen. Virol, 66(Pt 7), 1515-1522.
4. Klaes,R., Woerner,S.M., Ridder,R., Wentzensen,N., Dürst,M., Schneider,A., Lotz,B., Melsheimer,P. and von Knebel Doeberitz,M. (1999) Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res., 59, 6132-6136.
5. Tonon,S.A., Picconi,M.A., Bos,P.D., Zinovich,J.B., Galuppo,J., Alonio,L.V. and Teyssie,A.R. (2001) Physical status of the E2 human papilloma virus 16 viral gene in cervical preneoplastic and neoplastic lesions. J. Clin. Virol., 21, 129-134.
6. Lehn,H., Villa,L.L., Marziona,F., Hilgarth,M., Hillemans,H.G. and Sauer,G. (1988) Physical state and biological activity of human papillomavirus genomes in precancerous lesions of the female genital tract. J. Gen. Virol., 69(Pt 1), 187-196.
7. Schwarz,E., Freese,U.K., Gissmann,L., Mayer,W., Roggenbuck,B., Stremlau,A. and zur Hausen,H. (1985) Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature, 314, 111-114.
8. Choo,K.B., Pan,C.C. and Han,S.H. (1987) Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. Virology, 161, 259-261.
9. Jeon,S. and Lambert,P.F. (1995) Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: Implications for cervical carcinogenesis. Proc. Natl Acad. Sci. USA, 92, 1654-1658.
10. Wentzensen,N.,Ridder,R., Klaes,R., Vinokurova,S., Schaefer,U. and Doeberitz,M.K. (2002) Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions. Oncogene, 21, 419-426.
11. Dowhanick,J.J., McBride,A.A. and Howley,P.M. (1995) Suppression of cellular proliferation by the papillomavirus E2 protein. J. Virol., 69, 7791-7799.
12. Bechtold,V., Beard,P. and Raj,K. (2003) Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA. J. Virol., 77, 2021-2028.
13. Stanley,M.A., Browne,H.M., Appleby,M. and Minson,A.C. (1989) Properties of a non-tumorigenic human cervical keratinocyte cell line. Int. J. Cancer, 43, 672-676.
14. Alazawi,W., Pett,M., Arch,B., Scott,L., Freeman,T., Stanley,M.A. and Coleman,N. (2002) Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16. Cancer Res., 62, 6959-6965.
15. Lowy,D.R.and Howley,P.M. (2001) Papillomaviruses. In: Fields,B.N., Knipe,D.M., Howley,P.M. and Griffin,D.E., (eds) Fields' Virology. Lippincott Williams & Wilkins, Philadelphia, pp. 2231-2256.
16. Pett,M.R., Herdman,M.T., Palmer,R.D., Yeo,G.S.H., Shivji,M.K., Stanley,M.A. and Coleman,N. (2006) Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response. Proc. Natl Acad. Sci. USA, 103, 3822-3827.
17. Muñoz,N., Bosch,F.X., de Sanjosé,S., Herrero,R., Castellsagué,X., Shah,K.V., Snijders,P.J. and Meijer,C.J. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med., 348, 518-527.
18. Pett,M.R., Alazawi,W.O., Roberts,I., Dowen,S., Smith,D.I., Stanley,M.A. and Coleman,N. (2004) Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes. Cancer Res., 64, 1359-1368.
19. Jeon,S., Allen-Hoffmann,B.L. and Lambert,P.F. (1995) Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J. Virol., 69, 2989-2997.
20. Turek,L.P., Byrne,J.C., Lowy,D.R., Dvoretzky,I., Friedman,R.M. and Howley,P.M.(1982) Interferon induces morphologic reversion with elimination of extrachromosomal viral genomes in bovine papillomavirus-transformed mouse cells. Proc. Natl Acad. Sci. USA, 79, 7914-7918.
21. Chang,Y.E., Pena,L., Sen,G.C., Park,J.K. and Laimins.L.A. (2002) Long-term effect of interferon on keratinocytes that maintain human papillomavirus type 31. J. Virol., 76, 8864-8874.
22. Cirelli,R. and Tyring,S.K. (1994) Interferons in human papillomavirus infections. Antiviral Res., 24, 191-204.
23. Koromilas,A.E., Li,S. and Matlashewski,G. (2001) Control of interferon signaling in human papillomavirus infection. Cytokine Growth Factor Rev., 12, 157-170.
24. Higgins,G.D. Uzelin,D.M., Phillips,G.E., McEvoy,P., Marin,R. and Burrell,C.J. (1992) Transcription patterns of human papillomavirus type 16 in genital intraepithelial neoplasia: Evidence for promoter usage within the E7 open reading frame during epithelial differentiation. J. Gen. Virol., 73 (Pt 8), 2047-2057.
25. Der,S.D., Zhou,A., Williams,B.R. and Silverman,R.H. (1998) Identification of genes differentially regulated by inteferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl Acad. Sci. USA, 95, 15623-15628.
26. Freshney,R.I. (2000) Culture of Animal Cells: A Manual of Basic Technique. Wiley-Liss, New York.
27. Yee,C., Krishnan-Hewlett,I., Baker,C.C., Schlegel,R. and Howley,P.M. (1985) Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am. J. Pathol., 119, 361-366.
28. Ponchel.F., Toomes,C., Bransfield,K. et al. (2003) Real-time PCR based on SYBR-Green I fluorescence: An alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletions. BMC Biotechnol., 3, 18.
29. Moberg,M., Gustavsson,I. and Gyllensten,U. (2003) Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer. J. Clin. Microbiol., 41, 3221-3228.
30. Peitsaro,P., Johansson,B. and Syrjänen,S. (2002) Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J. Clin. Microbiol., 40, 886-891.
31. Koopman,G., Reutelingsperger,C.P, Kuijten,G.A., Keehnen,R.M., Pals,S.T. and van Oers,M.H. (1994) Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood, 84, 1415-1420.
32. Pfaffl,M.W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res., 29, e45.
33. Vandesompele,J., De Preter,K., Pattyn,F., Poppe,B., Van Roy,N., De Paepe,A. and Speleman,F. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol., 3, RESEARCH0034.1-0034.11.
34. Biron,C.A, and Sen,G.C. (2001) Interferons and Other Cytokines. In: Knipe,D.M. and Howley,P.M, (eds), Fields' Virology. Lippincott Williams & Wilkins, Philadelphia, pp. 321-344.
35. Samuel,C.E. (2001) Antiviral actions of interferons. Clin. Microbiol. Rev., 14, 778-809.
36. Dvoretzky,I., Shober,R., Chattopadhyay,S.K. and Lowy,D.R. (1980) A quantitative in vitro focus assay for bovine papilloma virus. Virology, 103, 369-375.
37. Law,M.F., Lowy,D.R., Dvoretzky,I. and Howley,P.M. (1981) Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences. Proc. Natl Acad. Sci. USA, 78, 2727-2731.
38. Agrawal,R., Pelkonen,J., Rytkönen,M. and Mäntyjärvi,R.A. (1992) Integration of bovine papillomavirus type 1 DNA and analysis of the amplified virus-cell junctions in transformed primary mouse fibroblasts. J. Gen. Virol., 73 (Pt 1), 201-206.
39. Kim,K.Y., Blatt,L. and Taylor,M.W. (2000) The effects of interferon on the expression of human papillomavirus oncogenes. J. Gen. Virol., 81, 695-700.
40. Takaoka,A., Hayakawa,S., Yanai,H. et al. (2003) Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature, 424, 516-523.
41. Webster,K., Parish,J., Pandya,M., Stern,P.L., Clarke,A.R. and Gaston,K. (2000) The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway. J. Biol. Chem., 275, 87-94.
42. Parish,J.L., Kowalczyk,A., Chen,H.T., Roeder,G.E., Sessions,R., Buckle,M. and Gaston,K. (2006) E2 proteins from high- and low-risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death, J. Virol., 80, 4580-4590.
43. Grm,H.S., Massimi,P., Gammoh,N. and Banks,L. (2005) Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein. Oncogene, 24, 5149-5164.
44. Gammoh,N., Grm,H.S., Massimi,P. and Bariks,L. (2006) Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator. J. Virol., 80, 1787-1797.
45. Chelbi-Alix,M.K., Quignon,F., Pelicano,L., Koken,M.H. and de The,H. (1998) Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J. Virol., 72, 1043-1051.
46. Day,P.M., Baker,C.C., Lowy,D.R. and Schiller,J.T. (2004) Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc. Natl Acad. Sci. USA, 101, 14252-14257.
47. Deng,W., Lin,B.Y., Jin,G., Wheeler,C.G., Ma,T., Harper,J.W., Broker,T.R. and Chow,L.T. (2004) Cyclin/CDK regulates the nucleocytoplasmic localization of the human papillomavirus E1 DNA helicase. J. Virol., 78, 13954-13965.
48. Swindle,C.S., Zou,N., Van Tine,B.A., Shaw,G.M., Engler,J.A. and Chow,L.T. (1999) Human papillomavirus DNA replication compartments in a transient DNA replication system. J. Virol., 73, 1001-1009.
49. Jul-Larsen,A., Visted,T., Karlsen,B.O., Rinaldo,C.H., Bjerkvig,R., Lønning,P.E. and Bøe,S.O. (2004) PML-nuclear bodies accumulate DNA in response to polyomavirus BK and simian virus 40 replication. Exp. Cell. Res., 298, 58-73.
50. Ruutu,M., Peitsaro,P., Johansson,B. and Syrjänen,S. (2002) Transcriptional profiling of a human papillomavirus 33-positive squamous epithelial cell line which acquired a selective growth advantage after viral integration. Int. J. Cancer, 100, 318-326.